Phase 1, TAK-915-1001, Single-Rising Dose, Multiple-Rising Dose, Drug-Drug Interaction, Relative Bioavailability, Food Effect, and Effect on Elderly Participants Study

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 12, 2015

Primary Completion Date

August 1, 2016

Study Completion Date

August 1, 2016

Conditions

Healthy Volunteers

Interventions

DRUG

TAK-915 suspension

TAK-915 oral suspension

DRUG

Midazolam

Midazolam oral solution

DRUG

Placebo

Placebo-matching TAK-915 suspension

DRUG

TAK-915 tablet

Trial Locations (1)

Austin